Picture of Lifeward logo

LFWD Lifeward News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Rewalk Robotics Ltd expected to post a loss of 6 cents a share - Earnings Preview

* Rewalk Robotics Ltd  RWLK.OQ   RWLK.O  is expected to show a
fall in quarterly revenue when it reports results on August 9. 
* The Yokneam, Israel-based company is expected to report   a
16.1% decrease in revenue to $1.4 million from $1.67 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
​* Refinitiv's mean analyst estimate for Rewalk Robotics Ltd is
for a loss of 6 cents per share. For the same quarter last year,
the company reported a loss of 22 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Rewalk Robotics
Ltd is $3.5​, about 58.6% above​ its last closing price
of $1.45. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.07       -0.07      -0.08     Missed  -14.3
 Dec. 31 2020  -0.14       -0.14      -0.14     Met     0
 Sep. 30 2020  -0.16       -0.16      -0.18     Missed  -12.5​
 Jun. 30 2020  -0.27       -0.27      -0.22     Beat    18.5
 Mar.          -0.26​      -0.26      -0.37     Missed  -42.3​
 31​ 2020​                                              
 Dec. 31 2019  -0.36       -0.36      -0.49     Missed  -36.1​
 Sep. 30 2019  -0.45       -0.45      -0.46     Missed  -2.2
 Jun. 30 2019  -0.49       -0.49      -0.88     Missed  -79.6
 This summary was machine generated August 6 at 13:12 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Lifeward

See all news